Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boiocchi

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Leukemia Research|January 1, 1990
A coordinated proto-oncogene expression characterizes MCF 247 murine leukemia virus-induced T-cell lymphomas irrespectively of proviral insertion affecting myc lociM Boiocchi, R Dolcetti, R Maestro, et al.
American Journal of Clinical Pathology|November 1, 1993
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineageR Dolcetti, A Carbone, V Zagonel, et al.
Oncogene|August 1, 1989
N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomasR Dolcetti, S Rizzo, A Viel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphomaG Toffoli, G Corona, G Cattarossi, et al.
British Journal of Clinical Pharmacology|December 12, 2001
Population pharmacokinetics and pharmacodynamics of oral etoposideG Toffoli, G Corona, R Sorio, et al.
International Journal of Cancer|May 16, 1998
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancerG Toffoli, A Russo, A Gallo, et al.
Journal of Chemotherapy (Florence, Italy)|June 26, 2004
Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicinG Toffoli, R Sorio, B Basso, et al.
International Journal of Cancer|July 15, 1999
Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosisD Gasparotto, T Vukosavljevic, S Piccinin, et al.
Oncogene|June 1, 1992
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynxR Maestro, R Dolcetti, D Gasparotto, et al.
The Journal of Rheumatology|August 1, 1994
The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphomaS De Vita, G Ferraccioli, V De Re, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Leukemia Research|January 1, 1990
A coordinated proto-oncogene expression characterizes MCF 247 murine leukemia virus-induced T-cell lymphomas irrespectively of proviral insertion affecting myc lociM Boiocchi, R Dolcetti, R Maestro, et al.
American Journal of Clinical Pathology|November 1, 1993
Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineageR Dolcetti, A Carbone, V Zagonel, et al.
Oncogene|August 1, 1989
N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomasR Dolcetti, S Rizzo, A Viel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphomaG Toffoli, G Corona, G Cattarossi, et al.
British Journal of Clinical Pharmacology|December 12, 2001
Population pharmacokinetics and pharmacodynamics of oral etoposideG Toffoli, G Corona, R Sorio, et al.
International Journal of Cancer|May 16, 1998
Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancerG Toffoli, A Russo, A Gallo, et al.
Journal of Chemotherapy (Florence, Italy)|June 26, 2004
Pharmacokinetic comparison of 120-hour infusion versus hyperfractionated oral administration of idarubicinG Toffoli, R Sorio, B Basso, et al.
International Journal of Cancer|July 15, 1999
Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosisD Gasparotto, T Vukosavljevic, S Piccinin, et al.
Oncogene|June 1, 1992
High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynxR Maestro, R Dolcetti, D Gasparotto, et al.
The Journal of Rheumatology|August 1, 1994
The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphomaS De Vita, G Ferraccioli, V De Re, et al.
Pageof 18